Compugen Ltd. Stock
Your prediction
Compugen Ltd. Stock
Heavy losses for Compugen Ltd. today as the stock fell by €0.000 (-3.440%).
Pros and Cons of Compugen Ltd. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Compugen Ltd. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Compugen Ltd. | -3.440% | -15.142% | 18.389% | -30.909% | 18.389% | 92.346% | - |
| Protalix Biotherapeutics Inc. | 13.710% | 10.734% | 28.105% | -15.808% | 28.105% | 32.567% | -46.448% |
| Intellia Therapeutics Inc | -4.310% | -10.311% | 42.070% | 11.592% | 42.070% | -71.763% | -79.193% |
| Chromadex Corp | -1.610% | -4.314% | -11.273% | -9.630% | -11.273% | 175.706% | 25.773% |
Comments
Compugen Ltd. (NASDAQ: CGEN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $4.00 price target on the stock.
Show more
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) had its price target lowered by analysts at Truist Financial Co. from $5.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CGEN provided by MarketBeat
